Literature DB >> 18841822

Extragastrointestinal stromal tumor of the urinary wall bladder: case report and review of the literature.

A Mekni1, I Chelly, H Azzouz, I Ben Ghorbel, S Bellil, S Haouet, N Kchir, M Zitouna, K Bellil.   

Abstract

Most mesenchymal tumours of the gastrointestinal tract are now referred to as gastrointestinal stromal tumours (GISTs). These tumours typically express c-kit (CD117) and CD34; 30-50% are (often focally) positive for alpha-smooth muscle actin, and all are negative for desmin and S100 protein. Recently, mutations in exon 11 of the c-kit gene have been identified as a molecular genetic marker for the subset of GISTs. In this report, we describe a mesenchymal tumour removed from the pelvic cavity of a 34-year-old man. The tumour was strongly attached to the external wall of the urinary bladder. The neoplasm grossly resembled a leiomyoma, and was histologically composed of sheets of spindle cells with a dense collagenous background. The mitotic activity was low (less then 1 per 50 high-power fields). Immunohistochemically, tumour cells were negative for alpha-smooth muscle actin and desmin and positive for CD117 and CD34. This case illustrates that tumours which are phenotypically and genotypically similar to GISTs may present in sites other than the tubular gastrointestinal tract.

Entities:  

Mesh:

Year:  2008        PMID: 18841822

Source DB:  PubMed          Journal:  Pathologica        ISSN: 0031-2983


  15 in total

1.  Bladder extragastrointestinal stromal tumor in an adolescent patient: A case-based review.

Authors:  Fan He; Zhenqiang Fang; Pei Zhu; Wei Huang; Longkun Li
Journal:  Mol Clin Oncol       Date:  2014-07-31

2.  Gastrointestinal stromal tumor presenting as a hormonally inactive adrenal mass.

Authors:  Márta Sereg; István Buzogány; Gábor Gonda; Zoltán Sápi; Eva Csöregh; Zsuzsa Jakab; Károly Rácz; Miklós Tóth
Journal:  Endocrine       Date:  2011-02       Impact factor: 3.633

3.  Extra-gastrointestinal stromal tumor of the pelvic cavity: case report.

Authors:  Hiroshi Hirano; Toshimi Yoshida; Hisashi Yoshimura; Masato Fukuoka; Noriko Ohmura; Yuusuke Nishizawa; Shiro Tachibana; Seiichi Hirota; Masataka Zozumi; Takashi Nishigami
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

4.  Primary extragastrointestinal stromal tumor of the pleura: A case report.

Authors:  Cai-Qing Zhang; DE-Gan Lu; Qing-Fa Liu; Wei Xiao
Journal:  Oncol Lett       Date:  2016-03-17       Impact factor: 2.967

Review 5.  Gastrointestinal stromal tumors.

Authors:  Alexander W Beham; Inga-Marie Schaefer; Philipp Schüler; Silke Cameron; B Michael Ghadimi
Journal:  Int J Colorectal Dis       Date:  2011-11-29       Impact factor: 2.571

6.  Extra-gastrointestinal stromal tumor of the liver diagnosed by ultrasound-guided fine needle aspiration cytology: a case report and review of the literature.

Authors:  Zhou-Yu Li; Qi-Lian Liang; Guo-Qiang Chen; Yuan Zhou; Qiu-Long Liu
Journal:  Arch Med Sci       Date:  2012-05-09       Impact factor: 3.318

7.  Gastrointestinal stromal tumor: a rare abdominal tumor.

Authors:  Shagufta Shaheen; Achuta K Guddati
Journal:  Case Rep Oncol       Date:  2013-03-20

Review 8.  An unexpected but interesting response to a novel therapy for malignant extragastrointestinal stromal tumor of the mesoileum: a case report and review of the literature.

Authors:  Hengping Li; Jun Li; Xingwen Li; Yaqiong Kang; Qiang Wei
Journal:  World J Surg Oncol       Date:  2013-08-05       Impact factor: 2.754

9.  An extragastrointestinal stromal tumor originating from the seminal vesicles: A case report and review of the literature.

Authors:  Yi Hou; Yinhuai Wang; Ran Xu; Duo Li; Xiaokun Zhao
Journal:  Oncol Lett       Date:  2013-07-26       Impact factor: 2.967

10.  An inflammatory myofibroblastic tumor exhibiting immunoreactivity to KIT: a case report focusing on a diagnostic pitfall.

Authors:  Tatsuki R Kataoka; Nobuhiro Yamashita; Ayako Furuhata; Masahiro Hirata; Takaki Ishida; Ichiro Nakamura; Seiichi Hirota; Hironori Haga; Eiji Katsuyama
Journal:  World J Surg Oncol       Date:  2014-06-18       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.